BIODEXA PHARMACEUTICALS-ADR (BDRX) Stock Analyst Ratings
USA - NASDAQ:BDRX - US59564R8806 - ADR
5.4 USD
+0.11 (+2.08%)
ChartMill assigns a Buy % Consensus number of 86% to BDRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 183.6. This target is 3300% above the current price.
BDRX was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about BDRX.
In the previous month the buy percentage consensus was at a similar level.
BDRX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-02-08 | Ladenburg Thalmann | Initiate | Buy |
BIODEXA PHARMACEUTICALS-ADR / BDRX FAQ
Can you provide the average price target for BIODEXA PHARMACEUTICALS-ADR stock?
7 analysts have analysed BDRX and the average price target is 183.6 USD. This implies a price increase of 3300% is expected in the next year compared to the current price of 5.4.
Can you provide the consensus rating for BIODEXA PHARMACEUTICALS-ADR stock?
The consensus rating for BIODEXA PHARMACEUTICALS-ADR (BDRX) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed BIODEXA PHARMACEUTICALS-ADR (BDRX)?
The number of analysts covering BIODEXA PHARMACEUTICALS-ADR (BDRX) is 7.